130 related articles for article (PubMed ID: 2654665)
1. Effect of oxoplatinum and CBDCA on renal functions in rats.
Láznícková A; Semecký V; Láznícek M; Zubr V; Koksál J; Kvĕtina J
Neoplasma; 1989; 36(2):161-9. PubMed ID: 2654665
[TBL] [Abstract][Full Text] [Related]
2. [Study on nephrotoxicity in rats receiving cis-diammine-1,1-cyclobutane dicarboxylate platinum II--special reference to morphological changes].
Kimura S; Nakajima Y; Hasegawa S; Tazaki H
Nihon Hinyokika Gakkai Zasshi; 1989 Apr; 80(4):517-25. PubMed ID: 2664296
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function.
Harland SJ; Newell DR; Siddik ZH; Chadwick R; Calvert AH; Harrap KR
Cancer Res; 1984 Apr; 44(4):1693-7. PubMed ID: 6367971
[TBL] [Abstract][Full Text] [Related]
4. The effect of second generation platinum cytostatics on mammalian cell proliferation.
Keprtová J; Smutná A; Minárová E; Vrána O
Neoplasma; 1990; 37(2):121-9. PubMed ID: 2188163
[TBL] [Abstract][Full Text] [Related]
5. Some effects of combination chemotherapy with cis-platinum on renal function in patients with nonseminomatous testicular carcinoma.
Meijer S; Sleijfer DT; Mulder NH; Sluiter WJ; Marrink J; Koops HS; Brouwers TM; Oldhoff J; van der Hem GK; Mandema E
Cancer; 1983 Jun; 51(11):2035-40. PubMed ID: 6340821
[TBL] [Abstract][Full Text] [Related]
6. Experimental studies on the pharmacokinetics and nephrotoxicity of carboplatin (cis-diammine-1, 1-cyclobutane dicarboxylate platinum II) in rats.
Ueda T; Yasumasu T; Uozumi J
J Toxicol Sci; 1991 Aug; 16(3):101-9. PubMed ID: 1942134
[TBL] [Abstract][Full Text] [Related]
7. [Nephrotoxicity and myelotoxicity of antineoplastic Pt(II) and Pt(IV) coordination compounds in rats].
Horn U; Härtl A; Neuhaus G; Stöckel U; Schröer HP; Hoffmann H
Arch Geschwulstforsch; 1989; 59(4):245-50. PubMed ID: 2802932
[TBL] [Abstract][Full Text] [Related]
8. Preclinical toxicology of platinum analogues in dogs.
Lelieveld P; van der Vijgh WJ; van Velzen D
Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1147-54. PubMed ID: 3308482
[TBL] [Abstract][Full Text] [Related]
9. Preclinical studies identifying carboplatin as a viable cisplatin alternative.
Harrap KR
Cancer Treat Rev; 1985 Sep; 12 Suppl A():21-33. PubMed ID: 3910219
[TBL] [Abstract][Full Text] [Related]
10. [Characteristics of the action of cisplatin and cycloplatam on the rat kidney].
Natochin IuV; Reznik LV; Brovtsyn VK; Ivanov VB; Miazina EM; Chel'tsov PA; Shakhmatova EI
Biull Eksp Biol Med; 1989 Jul; 108(7):52-4. PubMed ID: 2804301
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and plasma protein binding of two platinum cytostatics CHIP and CBDCA in rats.
Láznícková A; Láznícek M; Kvĕtina J; Drobník J
Cancer Chemother Pharmacol; 1986; 17(2):133-6. PubMed ID: 3521926
[TBL] [Abstract][Full Text] [Related]
12. Ototoxicity of cisplatin vs. platinum analogs CBDCA (JM-8) and CHIP (JM-9).
Schweitzer VG; Rarey KE; Dolan DF; Abrams G; Litterst CJ; Sheridan C
Otolaryngol Head Neck Surg; 1986 Apr; 94(4):458-70. PubMed ID: 3086808
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of side effects of platinum complexes (CDDP, CBDCA, CHIP) on rat bone marrow.
Prajda N; Kralovánszky J; Gal F; Kiss F; Kerpel-Fronius S
In Vivo; 1989; 3(4):267-70. PubMed ID: 2519864
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the effects of tetraplatin and cisplatin on renal function and gentamicin pharmacology in rats.
Engineer MS; Brown NS; Ho DH; Newman RA; Bulger RE
Toxicology; 1989 Dec; 59(2):151-62. PubMed ID: 2588264
[TBL] [Abstract][Full Text] [Related]
15. [Acute and subacute toxicity of antineoplastic Pt(II) and Pt(IV) coordination compounds in laboratory rodents].
Härtl A; Güttner J; Horn U; Jelinek F; Stöckel U; Schröer HP; Hoffmann H
Arch Geschwulstforsch; 1989; 59(4):239-44. PubMed ID: 2640563
[TBL] [Abstract][Full Text] [Related]
16. The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats.
Siddik ZH; Newell DR; Boxall FE; Harrap KR
Biochem Pharmacol; 1987 Jun; 36(12):1925-32. PubMed ID: 3297068
[TBL] [Abstract][Full Text] [Related]
17. The influence of platinum drugs on the radiation response of rat kidneys.
van Rongen E; Kuijpers WC; Baten-Wittwer A
Radiother Oncol; 1994 May; 31(2):138-50. PubMed ID: 8066193
[TBL] [Abstract][Full Text] [Related]
18. Acute and cumulative effects of carboplatin on renal function.
Sleijfer DT; Smit EF; Meijer S; Mulder NH; Postmus PE
Br J Cancer; 1989 Jul; 60(1):116-20. PubMed ID: 2679841
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
[TBL] [Abstract][Full Text] [Related]
20. Blood clearance of radioactively labelled cis-diammine 1,1-cyclobutane dicarboxylate platinum (II) (CBDCA) in cancer patients.
Sharma H; Thatcher N; Baer J; Zaki A; Smith A; McAucliffe CA; Crowther D; Owens S; Fox BW
Cancer Chemother Pharmacol; 1983; 11(1):5-7. PubMed ID: 6349844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
